Comparison of Nicolaides' risk evaluation for down's syndrome with a novel software: An analysis of 1,463 cases

Archives of Gynecology and Obstetrics

Volumn 275, Issue 6, 2007, Pages 469-474

  Schmidt, Peter ^a,b   Staboulidou, Ismini ^a   Soergel, Philipp ^a   Wüstemann, Max ^a   Hillemanns, Peter ^a   Scharf, Alexander ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b University of Heidelberg ^*  (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aneuploidy; Down syndrome; Nuchal translucency; Risk; Software

Indexed keywords

ARTICLE; CALCULATION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DOWN SYNDROME; FETUS; FETUS DEATH; FETUS MALFORMATION; FETUS OUTCOME; HOSPITAL DEPARTMENT; HUMAN; INTERMETHOD COMPARISON; KLINEFELTER SYNDROME; MEDICAL SCHOOL; NUCHAL TRANSLUCENCY MEASUREMENT; RISK ASSESSMENT; SPONTANEOUS ABORTION; TRIPLOIDY; TRISOMY 18; TURNER SYNDROME;

ADOLESCENT; ADULT; ALGORITHMS; CHROMOSOME DISORDERS; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SOFTWARE;

EID: 34249051661     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-006-0288-y     Document Type: Article

References (21)

1. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH (1998) UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 352:343-346
2. Pandya PP, Snijders RJ, Johnson SP, De Lourdes Brizot M, Nicolaides KH (1995) Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 102:957-962
3. Schuchter K, Wald N, Hackshaw AK, Hafner E, Liebhart E (1998) The distribution of nuchal translucency at 10-13 weeks of pregnancy. Prenat Diagn 18:281-286
4. Krampl E, Wertaschnigg D, Husslein P (2002) First-trimester screening for Down's syndrome. Geburtshilfe Frauenheilkd 62:843-848
5. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K (1992) Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304:867-869
6. Snijders RJ, Holzgreve W, Cuckle H, Nicolaides KH (1994) Maternal age-specific risks for trisomies at 9-14 weeks' gestation. Prenat Diagn 14:543-552
7. Braithwaite JM, Morris RW, Economides DL (1996) Nuchal translucency measurements: frequency distribution and changes with gestation in a general population. Br J Obstet Gynaecol 103:1201-1204
8. Wald N, Stone R, Cuckle HS, Grudzinskas JG, Barkai G, Brambati B, Teisner B, Fuhrmann W (1992) First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome. BMJ 305:28
9. Kowalcek I, Mühlhoff A, Bieniakiewizc I, Gembruch U (2001) Non-invasive and invasive prenatal diagnosis and psychological challenges for the pregnant patient. Geburtshilfe Frauenheilkd 61:593-598
10. Snijders RJM, Nicolaides KH (1996) Assessment of risks. In: Snijders RJM, Nicolaides KH (eds) Ultrasound markers for fetal chromosomal defects. Parthenon Publishing, Carnforth, UK, pp 109-113
11. Palomaki GE, Haddow JE (1987) Maternal serum alpha-fetoprotein, age, and Down syndrome risk. Am J Obstet Gynecol 156:460-463
12. Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH (1999) Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 13:167-170
13. Nicolaides KH, Sebire N, Snijders RJM (1999) Nuchal translucency and chromosomal anomalies. In: Nicolaides KH, Sebire N, Snijders RJM (eds) The 11-14-week scan: the diagnosis of fetal abnormalities. Parthenon Publishing, Carnforth, UK, pp 3-72
14. Wald NJ, Hackshaw AK (1997) Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenat Diagn 17:821-829
15. Scharf A, Schmidt P, Seppelt M, Maul H, Wuestemann M, Sohn C (2003) Vergleich der Risikokalkulation für Trisomie 21 nach Nicolaides mit einer neu entwickelten Software: Retrospektive Analyse an 744 Fällen, Geburtsh Frauenheilk 63:148-152
16. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH (1999) Screening program for trisomy 21at 10/14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin an prgnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13:231-237
17. Scharf A, Bock N, Maul H, Sohn C (2006) Analyse des Nackentransparenz (NT-)Screeningkonzepts an der Frauenklinik der MHH: Eine prospektive Follow-up-Studie. Z Geburtshilfe Neonatol 210(3):99-106
18. Souka A, Heath V (1999) Increased nuchal translucency with normal karyotype. In: Nicolaides KH, Sebire N, Snijders RJM (eds) The 11-14-week scan: the diagnosis of fetal abnormalities. Parthenon Publishing, Carnforth, UK, pp 73-97
19. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH (1999) Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 318(7176):81-85
20. Harlap S; Shiono PH (1980) Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet 2(8187):173-176
21. Chitty LS, Hunt GH, Moore J, Lobb MO (1991) Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population. BMJ 303:1165-1169